Skip to content

Corvel CRVL Options canceled (in dollars per share)

Options canceled (in dollars per share) at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
$0.00

Other financials

Income statement

See full
Revenue$248.5M+7.4%
Gross profit$63.0M+8.3%
Net income$31.0M+17.4%
EPS (diluted)$0.61+19.6%

Balance sheet

See full
Cash & equivalents$233.1M+36.6%
Total debt$28.1M+0.1%
Total equity$394.2M+22.4%
Total assets$643.0M+17.8%

Cash flow

See full
Operating cash flow$29.5M+28.6%
CapEx$9.2M+5.9%
Free cash flow$20.3M+42.3%

Valuation

See full
Market cap$3.03B-51.4%
Enterprise value$2.82B-53.8%
P/E27.4×-38.0×
P/S3.2×-3.8×

Profitability

See full
Gross margin24.3%+0.9pp
Net margin11.5%+0.9pp
FCF margin11.5%+1.3pp

Returns & leverage

See full
Return on equity30.8%-2.6pp
Debt / equity0.1×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.

The official record: Corvel’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's options canceled (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvel's options canceled (in dollars per share)?
Corvel (CRVL) reported options canceled (in dollars per share) of $68.27 in Q4 2025.
How has Corvel's options canceled (in dollars per share) changed year-over-year?
Corvel's options canceled (in dollars per share) decreased by 0.3% year-over-year, from $68.49 to $68.27.